Akebia Therapeutics dba Keryx Biopharmaceutials, Inc

2 FDA enforcement actions

2 Total Recalls

0 Class I

1 Class II

1 Class III

Firm Details

Product Types: drug
States: MA

All Recalls

Class III: Low Risk 01/29/2021 drug

Failed Dissolution Specifications
Class II: Risk 12/09/2020 drug

CGMP Deviations

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.